Skip to main content
Clinical Trials/NCT06158217
NCT06158217
Recruiting
Not Applicable

Effect of Ultrasound Combined With Microbubbles on Blood Perfusion in Invasive Breast Cancer

Beijing Friendship Hospital1 site in 1 country30 target enrollmentSeptember 29, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Invasive Breast Cancer
Sponsor
Beijing Friendship Hospital
Enrollment
30
Locations
1
Primary Endpoint
area under the curve (AUC)
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

Blood perfusion insufficiency and hypoxia are the main causes of drug resistance to chemotherapy in breast cancer. Increasing blood perfusion can improve drug delivery. The cavitation effect of ultrasound-stimulated microbubbles (USMBs) is known to enhance tumor blood perfusion, so we conducted a prospective human study to investigate the effects of USMBs on hemoperfusion in invasive breast cancer (IBC).

Detailed Description

patients with IBC were selected from the breast surgery department of our hospital. To induce an enhanced perfusion effect, IBC tumors were treated with SonoVue® microbubbles (MBs) stimulated by ultrasound, with a mechanical index (MI) of 0.2-0.3; 1 mL of SonoVue® MBs were injected at 3.5-min intervals three times for a USMB treatment lasting 10 min. The contrast-enhanced ultrasound (CEUS) parameters peak intensity (PI), area under the curve (AUC), and perfusion area were used to evaluate the changes in blood perfusion.

Registry
clinicaltrials.gov
Start Date
September 29, 2022
End Date
May 6, 2025
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Clinical diagnosis of Invasive Breast Cancer
  • patients scheduled to undergo surgical resection
  • maximum lesion diameter \< 4 cm
  • age over 18 years

Exclusion Criteria

  • patients with allergies to SonoVue®
  • patients with severe cardiopulmonary insufficiency,
  • patients who had already received neoadjuvant chemotherapy
  • pregnant women
  • individuals with mental illness
  • Patients who refused to participate in the study

Outcomes

Primary Outcomes

area under the curve (AUC)

Time Frame: 15 minutes after the USMB procedure

AUC represents the total amount of MB passing through the ROI during perfusion; thus, a larger AUC corresponds to greater perfusion in the ROI.

changes in peak intensity (PI)

Time Frame: 15 minutes after the USMB procedure

PI represents the quantitative scale of the highest average concentration of microbubble (MB) in the region of interest (ROI); thus, a larger PI corresponds to a higher concentration of MB in the ROI.

percentage increase in the perfusion area (%) of tumor

Time Frame: 15 minutes after the USMB procedure

The percentage increase in the perfusion area (%) was calculated as follows: (perfusion area after the USMB procedure - perfusion area before the USMB procedure) × 100%/perfusion area before the USMB procedure. The greater "percentage increase of perfusion area (%)", the more significant the improvement of blood perfusion.

Study Sites (1)

Loading locations...

Similar Trials